These observations would suggest early tumor clearance following STING therapy via lymphocyte independent mechanisms, although UPS tumors could not be cleared beyond 14 days without an intact lymphocyte compartment. The gene discussed is STING1; the disease is undifferentiated pleomorphic sarcoma.